Truist Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
18,583
-1,038
-5% -$95.3K ﹤0.01% 1428
2025
Q4
$1.76M Sell
19,621
-4,309
-18% -$409K ﹤0.01% 1369
2025
Q3
$2.36M Sell
23,930
-2,889
-11% -$286K ﹤0.01% 1258
2025
Q2
$2.45M Buy
26,819
+6,867
+34% +$664K ﹤0.01% 1180
2025
Q1
$2.26M Buy
19,952
+284
+1% +$30.4K ﹤0.01% 1162
2024
Q4
$2.08M Sell
19,668
-4,189
-18% -$449K ﹤0.01% 1218
2024
Q3
$2.58M Sell
23,857
-18,106
-43% -$1.98M ﹤0.01% 1125
2024
Q2
$4.55M Sell
41,963
-2,147
-5% -$253K 0.01% 892
2024
Q1
$5.82M Sell
44,110
-9,624
-18% -$1.2M 0.01% 834
2023
Q4
$6.54M Sell
53,734
-10,723
-17% -$1.2M 0.01% 768
2023
Q3
$7.23M Buy
64,457
+3,248
+5% +$412K 0.01% 701
2023
Q2
$8.91M Buy
61,209
+6,113
+11% +$831K 0.01% 622
2023
Q1
$7.12M Buy
55,096
+1,746
+3% +$219K 0.01% 702
2022
Q4
$6.8M Sell
53,350
-2,523
-5% -$293K 0.01% 709
2022
Q3
$5.84M Sell
55,873
-1,712
-3% -$188K 0.01% 724
2022
Q2
$6.05M Sell
57,585
-117,879
-67% -$14M 0.01% 735
2022
Q1
$22.4M Sell
175,464
-1,568
-0.9% -$189K 0.04% 392
2021
Q4
$21.8M Sell
177,032
-2,558
-1% -$335K 0.03% 407
2021
Q3
$25.5M Sell
179,590
-20,536
-10% -$3.02M 0.04% 351
2021
Q2
$31.2M Sell
200,126
-5,343
-3% -$865K 0.05% 328
2021
Q1
$31.9M Sell
205,469
-2,907
-1% -$450K 0.06% 301
2020
Q4
$31.2M Sell
208,376
-94,375
-31% -$13.3M 0.06% 286
2020
Q3
$40M Sell
302,751
-4,373
-1% -$571K 0.09% 219
2020
Q2
$35.6M Sell
307,124
-177,894
-37% -$20.5M 0.08% 240
2020
Q1
$47.6M Sell
485,018
-17,928
-4% -$2.35M 0.13% 177
2019
Q4
$73.1M Buy
502,946
+494,577
+5,910% +$68.3M 0.15% 151
2019
Q3
$1.12M Sell
8,369
-512
-6% -$66.1K 0.02% 430
2019
Q2
$1.01M Sell
8,881
-2,288
-20% -$268K 0.02% 454
2019
Q1
$1.39M Sell
11,169
-1,883
-14% -$214K 0.02% 415
2018
Q4
$1.31M Sell
13,052
-1,231
-9% -$138K 0.03% 409
2018
Q3
$1.82M Sell
14,283
-121
-0.8% -$14.4K 0.03% 382
2018
Q2
$1.56M Sell
14,404
-440
-3% -$47.9K 0.03% 399
2018
Q1
$1.57M Sell
14,844
-2,025
-12% -$235K 0.03% 406
2017
Q4
$1.98M Sell
16,869
-3,435
-17% -$388K 0.04% 370
2017
Q3
$2.31M Sell
20,304
-30,789
-60% -$3.55M 0.04% 338
2017
Q2
$6.37M Buy
51,093
+889
+2% +$105K 0.13% 203
2017
Q1
$5.95M Buy
50,204
+780
+2% +$88.4K 0.12% 207
2016
Q4
$4.95M Buy
49,424
+6,161
+14% +$660K 0.1% 230
2016
Q3
$5.46M Sell
43,263
-1,877
-4% -$232K 0.11% 214
2016
Q2
$5.28M Sell
45,140
-764
-2% -$86.5K 0.11% 212
2016
Q1
$4.75M Buy
45,904
+208
+0.5% +$20.1K 0.12% 196
2015
Q4
$4.55M Buy
45,696
+8,493
+23% +$831K 0.12% 199
2015
Q3
$3.39M Buy
37,203
+19,741
+113% +$1.98M 0.09% 248
2015
Q2
$1.85M Sell
17,462
-747
-4% -$82.7K 0.05% 303
2015
Q1
$2.08M Buy
18,209
+1,611
+10% +$184K 0.06% 279
2014
Q4
$1.83M Sell
16,598
-913
-5% -$96.2K 0.05% 295
2014
Q3
$1.71M Sell
17,511
-992
-5% -$97.6K 0.05% 291
2014
Q2
$1.87M Sell
18,503
-590
-3% -$57.6K 0.06% 284
2014
Q1
$1.75M Buy
19,093
+41
+0.2% +$3.78K 0.06% 290
2013
Q4
$1.72M Buy
19,052
+441
+2% +$38.2K 0.06% 284
2013
Q3
$1.48M Sell
18,611
-1,558
-8% -$123K 0.05% 293
2013
Q2
$1.47M Buy
+20,169
New +$1.51M 0.05% 278

Other funds holding ZBH

Truist Financial's ZBH Position: Q1 2026 in Review

Truist Financial reduced its Zimmer Biomet (ZBH) stake by 5.3% in Q1 2026, selling an estimated $95.3K and leaving 18,583 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Truist Financial first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $73.1M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Truist Financial held 18,583 shares of Zimmer Biomet worth $1.68M as of Q1 2026.
  • Truist Financial sold 1,038 Zimmer Biomet shares in Q1 2026, an estimated $95.3K.
  • Zimmer Biomet made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #1428 holding.
  • Truist Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Truist Financial's Zimmer Biomet position peaked at $73.1M in Q4 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.